Correlation Between 23Andme Holding and VistaGen Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and VistaGen Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and VistaGen Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and VistaGen Therapeutics, you can compare the effects of market volatilities on 23Andme Holding and VistaGen Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of VistaGen Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and VistaGen Therapeutics.

Diversification Opportunities for 23Andme Holding and VistaGen Therapeutics

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between 23Andme and VistaGen is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and VistaGen Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VistaGen Therapeutics and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with VistaGen Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VistaGen Therapeutics has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and VistaGen Therapeutics go up and down completely randomly.

Pair Corralation between 23Andme Holding and VistaGen Therapeutics

Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the VistaGen Therapeutics. In addition to that, 23Andme Holding is 2.84 times more volatile than VistaGen Therapeutics. It trades about -0.12 of its total potential returns per unit of risk. VistaGen Therapeutics is currently generating about -0.19 per unit of volatility. If you would invest  322.00  in VistaGen Therapeutics on September 3, 2024 and sell it today you would lose (38.00) from holding VistaGen Therapeutics or give up 11.8% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

23Andme Holding Co  vs.  VistaGen Therapeutics

 Performance 
       Timeline  
23Andme Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 23Andme Holding Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
VistaGen Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VistaGen Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

23Andme Holding and VistaGen Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 23Andme Holding and VistaGen Therapeutics

The main advantage of trading using opposite 23Andme Holding and VistaGen Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, VistaGen Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VistaGen Therapeutics will offset losses from the drop in VistaGen Therapeutics' long position.
The idea behind 23Andme Holding Co and VistaGen Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world